InvestorsHub Logo
Followers 118
Posts 11972
Boards Moderated 0
Alias Born 12/18/2003

Re: None

Wednesday, 02/21/2024 10:41:54 AM

Wednesday, February 21, 2024 10:41:54 AM

Post# of 233150
Again just to explain to some who don’t understand MOA of leronlimab , and generally medicine .

I don’t think we will be going for approval for Covid anymore, maybe Long Covid . ..
We don’t need to restrict LL with this .

The same immune problem as in Covid happening with most of infections , so most probably that’s what we will be going with .
Immune dysregulation !!

They starting already with immune activation , and inflammation in HIV ..

After that I will expect other infections will follow but in group not single virus , probably sepsis , where we don’t need to specify what was the agent , just the immune dysregulation , which is a reason patients die ,
and until now we don’t have any good drugs without severe side effects .

We need only one approval , and then we snowballing imo

Dr Jay trying now to peer review and publish our CD12..
All doctors and imo BP , will be the most curious in our 82% mortality benefit above ALL other drugs , when LL is in the system .
And leronlimab is not an antiviral drug , it is immunemodulator..
This is such an unbelievable result , I can’t wait to make it public to a medical community !!!
I can’t understand why it was not done until now ..

All imo
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News